What does CUSIP 695127100 represent in this 13F holders report?

CUSIP 695127100 is the security identifier for PCRX - Pacira BioSciences, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held PCRX - Pacira BioSciences, Inc. - Common Stock in Q2 2017?

191 institutional investors reported PCRX - Pacira BioSciences, Inc. - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

Pacira BioSciences, Inc. - Common Stock (PCRX)

CUSIP: 695127100

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock
Shares outstanding: 40,532,351
Total 13F shares: 41,206,727
Share change: +118,567
Total reported value: $1,966,090,329
Put/Call ratio: 68%
Price per share: $47.70
Number of holders: 191
Value change: +$10,414,759
Number of buys: 115
Number of sells: 79

Quarterly Holders Quick Answers

What is CUSIP 695127100?
CUSIP 695127100 identifies PCRX - Pacira BioSciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 695127100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PCRX - Pacira BioSciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	7.9%	3,183,787	$145,180,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	7.1%	2,860,092	$130,420,000	—	31 Mar 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	6%	2,440,280	$111,277,000	—	31 Mar 2017	13F
PFM Health Sciences, LP	13F	Company	4%	1,627,277	$74,204,000	—	31 Mar 2017	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	4%	1,608,847	$73,363,000	—	31 Mar 2017	13F
Alyeska Investment Group, L.P.	13F	Company	3.5%	1,413,193	$64,442,000	—	31 Mar 2017	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	3%	1,224,814	$55,852,000	—	31 Mar 2017	13F
PointState Capital LP	13F	Company	3%	1,205,900	$54,989,000	—	31 Mar 2017	13F
DARUMA CAPITAL MANAGEMENT LLC	13F	Company	2.9%	1,158,699	$52,837,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	2.7%	1,107,356	$50,499,000	—	31 Mar 2017	13F
HealthCor Management, L.P.	13F	Company	2.7%	1,100,000	$50,160,000	—	31 Mar 2017	13F
Clearbridge Investments, LLC	13F	Company	2.7%	1,087,752	$49,601,000	—	31 Mar 2017	13F
MACQUARIE GROUP LTD	13F	Company	2.7%	1,074,770	$49,010,000	—	31 Mar 2017	13F
Rock Springs Capital Management LP	13F	Company	2.5%	1,000,000	$45,600,000	—	31 Mar 2017	13F
Consonance Capital Management LP	13F	Company	2.4%	972,535	$44,348,000	—	31 Mar 2017	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	2.3%	928,527	$42,573,000	—	31 Mar 2017	13F
Stephens Investment Management Group LLC	13F	Company	2.2%	897,455	$40,924,000	—	31 Mar 2017	13F
FMR LLC	13F	Company	2.2%	878,719	$40,070,000	—	31 Mar 2017	13F
WADDELL & REED FINANCIAL INC	13F	Company	1.8%	725,651	$33,089,000	—	31 Mar 2017	13F
Invesco Ltd.	13F	Company	1.7%	680,903	$31,050,000	—	31 Mar 2017	13F
CADIAN CAPITAL MANAGEMENT, LP	13F	Company	1.5%	615,000	$28,044,000	—	31 Mar 2017	13F
Elk Creek Partners, LLC	13F	Company	1.4%	552,116	$25,176,000	—	31 Mar 2017	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	1.2%	501,470	$22,867,000	—	31 Mar 2017	13F
OAK RIDGE INVESTMENTS LLC	13F	Company	1.2%	484,538	$22,095,000	—	31 Mar 2017	13F
PUTNAM INVESTMENTS LLC	13F	Company	1.2%	466,616	$21,278,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	1.1%	463,240	$21,124,000	—	31 Mar 2017	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	1.1%	444,608	$20,274,000	—	31 Mar 2017	13F
Avoro Capital Advisors LLC	13F	Company	1%	410,000	$18,696,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	1%	405,192	$18,477,000	—	31 Mar 2017	13F
Standard Investments LLC	13F	Company	0.99%	399,496	$18,217,000	—	31 Mar 2017	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.88%	356,296	$16,960,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.91%	367,089	$16,739,000	—	31 Mar 2017	13F
NORGES BANK	13F	Company	0.82%	332,219	$15,149,000	—	31 Mar 2017	13F
ROYAL BANK OF CANADA	13F	Company	0.7%	283,822	$12,944,000	—	31 Mar 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.7%	282,531	$12,884,000	—	31 Mar 2017	13F
BARCLAYS PLC	13F	Company	0.67%	270,421	$12,331,000	—	31 Mar 2017	13F
Tamarack Advisers, LP	13F	Company	0.65%	265,000	$12,084,000	—	31 Mar 2017	13F
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO	13F	Company	0.62%	251,088	$11,450,000	—	31 Mar 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.59%	239,474	$10,920,000	—	31 Mar 2017	13F
Cortina Asset Management, LLC	13F	Company	0.54%	219,846	$10,025,000	—	31 Mar 2017	13F
BAILLIE GIFFORD & CO	13F	Company	0.53%	213,600	$9,740,000	—	31 Mar 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.52%	212,792	$9,703,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.51%	206,435	$9,415,000	—	31 Mar 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.46%	185,354	$8,452,000	—	31 Mar 2017	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.43%	175,292	$7,993,314	—	31 Mar 2017	13F
Epoch Investment Partners, Inc.	13F	Company	0.42%	169,283	$7,719,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.41%	164,727	$7,512,000	—	31 Mar 2017	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.4%	160,978	$7,341,000	—	31 Mar 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.38%	152,725	$6,964,000	—	31 Mar 2017	13F
Hodges Capital Management Inc.	13F	Company	0.36%	145,000	$6,612,000	—	31 Mar 2017	13F

Institutional Holders of Pacira BioSciences, Inc. - Common Stock (PCRX) as of Q2 2017

As of 30 Jun 2017, Pacira BioSciences, Inc. - Common Stock (PCRX) was held by 191 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,206,727 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Partner Fund Management, L.P., HealthCor Management, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, DARUMA CAPITAL MANAGEMENT LLC, STATE STREET CORP, Clearbridge Investments, LLC, and MACQUARIE GROUP LTD. This page lists 191 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

187

Q2 2017 holders

191

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.